Chloroprocaine hydrochloride

307.2161

306.090179

223-371-2

LT7Z1YW11H

DTXSID6048595

C47444

2922492050

41.57000

3.62590

177 °C

402.6ºC at 760 mmHg

NONH for all modes of transport

Stable. Incompatible with strong oxidizing agents.

P264, P270, P301+P310, P321, P330, P405, P501

H301

|Danger|H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]|P264, P270, P301+P310, P321, P330, P405, and P501|Aggregated GHS information provided by 3 companies from 1 notifications to the ECHA C&L Inventory.

Intrathecal anaesthesia|Ocular surface anaesthesia|Epidural anaesthesia|Peripheral nerve block (local anaesthesia by perineural injection)

Drugs that block nerve conduction when applied locally to nerve tissue in appropriate concentrations. They act on any part of the nervous system and on every type of nerve fiber. In contact with a nerve trunk, these anesthetics can cause both sensory and motor paralysis in the innervated area. Their action is completely reversible. (From Gilman AG, et. al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed) Nearly all local anesthetics act by reducing the tendency of voltage-dependent sodium channels to activate. (See all compounds classified as Anesthetics, Local.)

2-chloroprocaine

Human Drugs -> EU pediatric investigation plans|Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients